Original articleThe relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension
References (13)
- et al.
Relation of weight change to changes in atherogenic traits: The Framingham Study
J Chron Dis
(1974) - et al.
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension: The Oslo Study
Am J Med
(1978) - et al.
Elevation of serum lipid levels during diuretic therapy of hypertension
Am J Med
(1976) One year results of hypertension management in the Multiple Risk Factor Intervention Trial
Circulation
(1978)Elevated serum uric acid levels during treatment with antihypertensive drugs
Acta Med Scand
(1979)- et al.
Increases in serum lipids during treatment of hypertension with thiazide type diuretics: Importance of weight change
Circulation
(1978)
Cited by (35)
The metabolic syndrome: A critical appraisal based on the CUORE epidemiologic study
2009, Preventive MedicineCitation Excerpt :However, other investigations – e.g., the Framingham Offspring and CARDIA studies (Wilson et al., 1999; Lloyd-Jones et al., 2007) – reported both cross-sectional and prospective data on this matter concordant with CUORE findings. Concordant data are also available from clinical trials on the relation of weight change to change the other MetS traits (Farinaro et al., 1977; Heyden et al., 1985; Stamler et al., 1997; Diabetes Prevention Program Research Group, 2002). Such findings prevail with use of either BMI (with its limitations), or waist circumference (WC), or both, as in the CUORE Project.
Development of blood pressure and the incidence of hypertension in men and women. Over an 18-year Period. Results of the Nijmegen Cohort Study
1999, Journal of Clinical EpidemiologySecular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986 to 1996
1999, Journal of PediatricsEffect of insulin on renal sodium and uric acid handling in essential hypertension
1996, American Journal of Hypertension
- ∗
Research upon which this publication is based was performed pursuant to Contract Nos. NO1-HV-12433-42; NO1-HV-22931, 37–39, 45; NO1-HV-32933; NO1-HV-72915 and NO1-HV-82915 with the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services.